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Glands were the first type of tissues in which the permissive role of gap junctions in the cell-to-cell transfer of membrane-impermeant
molecules was shown. During the 40 years that have followed this seminal finding, gap junctions have been documented in all types of
multicellular secretory systems, whether of the exocrine, endocrine or pheromonal nature. Also, compelling evidence now indicates that gap
junction-mediated coupling, and/or the connexin proteins per se, play significant regulatory roles in various aspects of gland functions, ranging
from the biosynthesis, storage and release of a variety of secretory products, to the control of the growth and differentiation of secretory cells, and
to the regulation of gland morphogenesis. This review summarizes this evidence in the light of recent reports.
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Secretion is a widespread and diversified cell function that,
in most cases, is accomplished by multi-cellular glands. Within
these organs, secretory cells coordinate their functioning by
exchanging information with each other, and possibly also with
nearby vascular and mesenchymal cells, via both indirect (i.e.,
neurotransmitter-, hormone-, calcium-mediated, . . .) and direct
communication mechanisms (i.e., cell adhesion molecule-,
integrin-, junction-mediated, . . .) [1–3]. In vertebrates, a
consistent, if not obligatory feature of this communication
network, is the cell-to-cell channels made of connexin proteins,
that cluster to form gap junctions [1–10]. Thus, it has long
been known that these specialized membrane micro-domains
connect a variety of secretory cells, irrespective of their
endocrine or exocrine nature, the type of secretory productmade, the mechanism of its release and the type of regulation
by stimuli and inhibitors [1–10]. Since, a large body of
circumstantial evidence has accumulated, indicating that gap
junctions are required for the fine regulation of the biosynthe-
sis, storage and release of various secretory products [1–10].
With the increasing knowledge on the connexin family, some
of this work has been recently revisited with more specific
tools, and in more physiologically relevant models, confirming
that distinct connexin isoforms are implicated in the fine in
vivo tuning of the biosynthesis and release of secretory
products [2,3,9,10]. Recent work has also provided some
insight about the reason why different connexins have been
preferred by some types of secretory cells, while being
excluded by others [11–13].
Here, we have reviewed the distribution and function of
these connexins that are expressed by endocrine and exocrine
Fig. 2. Gap junctions differ between exocrine and endocrine cells of pancreas.
(A) Electron microscopy shows that the membranes of adjacent pancreatic
acinar cells, identified by the typical ultrastructure of enzyme-containing
secretory granules (white arrow) come into contact at large gap junctions
(between the black arrows). (B) Freeze-fracture reveals that these junctions
usually comprise several hundreds-thousands connexons, which are know by
immunolabeling to be made of Cx26 and Cx32. (C) Gap junctions are much
more minute between the insulin-producing h-cells of pancreatic islets. (D)
Freeze-fracture reveals that each h-cell plaque comprises only a few dozen
connexons, which are know by immunolabeling to be made of Cx36. Typically,
h-cell gap junctions are clustered in restricted domains of the cell membrane, in
close contact with tight junction fibrils. Bar, 300 nm in panels A and C, and 100
nm in panels B and D.
Fig. 3. Exocrine and endocrine pancreatic cells express different connexins. (A
Phase-contrast microscopy reveals the close apposition of the exocrine acina
cells and of the endocrine islet cells, in a cryo-section of a control mouse
pancreas. (B) Immunolabeling of the same field with antibodies to Cx32 (red
and Cx36 (green) reveal that the former protein forms large gap junction
plaques in the exocrine acini (above the dotted line), whereas the latter forms
minute plaques in the central, h-cell-rich region of an endocrine islet (below the
dotted line). Note the paucity of Cx36 at the islet periphery, which is formed
mostly by glucagon-, somatostatin- and pancreatic polypeptide-producing cells
Scale bar, 12 Am.
Fig. 1. The exocrine and endocrine cells of pancreas are organized within
independent, closely apposed units. Under the electron microscope, a freeze-
fracture replica of a rat pancreas reveals the close apposition of exocrine acinar
cells, identified by the large, spherical secretory granules containing a mixture
of digestive enzymes (above the dotted line), and the endocrine cells of a
pancreatic islet identified by the much smaller secretory granules containing
either insulin, glucagon, somatostatin or pancreatic polypeptide (below the
dotted line). Scale bar, 1.5 Am.
L. Michon et al. / Biochimica et Biophysica Acta 1719 (2005) 82–10184glands, in light of these recent studies. The reader is referred to
previous reviews [1–10] for a comprehensive coverage of the
early studies on this topic.
2. Exocrine and endocrine cells express different connexin
isoforms
It has long been documented that whereas most secretory
cells of exocrine glands express Cx26 and Cx32 but usually
not Cx43, the latter protein is the predominant connexin
isoform of endocrine cells [11], including when the two
types of cells closely interact within a very same organ (Fig.
1). Hence, and with the exception of glands which have
both endocrine–exocrine features, for phylogenetic, embry-
ological or physiological reasons [3,11], there appears to be
an almost alternative choice of different connexin isoforms
depending on whether secretory cells discharge their
products into the external environment or into the blood.
Often, the various connexins chosen to form the connexons
also pack into morphologically different gap junction
plaques in exocrine and endocrine cells (Figs. 2 and 3).
No data yet dispute this differential distribution, which is
observed in various animal species, even though Cx26 has
now been documented between the endocrine cells of the
pineal gland [14] and the anterior pituitary [15]. However,
other connexin isoforms have now been added to the list of
proteins making gap junctions of secretory cells. Thus,
Cx36, Cx40 and Cx45 have been documented in selected
endocrine cells [3], whereas Cx30 has been shown to be co-expressed with Cx26 and Cx32 in an exocrine gland [16].
Thus, if there is not a specific ‘‘endocrine’’ or ‘‘exocrine’’
connexin, there is certainly a highly conserved pattern of)
r
)
.
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systems. In view of recent studies relating different connexin
isoforms to different conductance, permeability and regula-
tory characteristics of gap junctional channels [17–20], it is
most likely that this differential selection was imposed, or
became selected during evolution, in order to match the
requirements for specific gap junction-permeant molecules to
the various needs of different types of secretory cells. It will
be difficult to test this hypothesis experimentally, inasmuch
as most of the ions and metabolites that permeate gap
junction channels are also the very same molecules that are
central to the proper control of the main steps of several
secretory processes. However, the two studies in which
Cx32 was expressed ectopically, either by knock-in of the
Gjb1 gene at the Gja1 locus [21; the nomenclature of the
connexin genes is given at http://www.informatics.jax.org/]
or by transgenic over expression of the cognate cDNA in a
cell type that only expresses Cx36 [22], have documented
an altered function of various target cells, including the
exocrine mammary gland, the exocrine and endocrine cells
of testis and the endocrine insulin-producing cells of
pancreatic islets [21,22]. These data indicate that specific
connexin patterns are required for proper in vivo secretion
of various products. Recent studies have provided some
insight about the mechanism whereby exocrine and endo-
crine cells may select different connexins. Thus, the
characterization of the 5V regulatory region of the humanTable 1
Distribution of connexins in secretory systems
Connexin Organ Cell type Sec
Cx26 and Cx32 Pancreas Acinar cells 20
Lacrymal glands Acinar cells Ion
Liver Hepatocytes Bil
Stomach Parietal cells Hy
Salivary glands Acinar cells Enz
Mammary glands Alveolar cells Pro
Testis Sertoli cells Pep
Cx30 Mammary glands Alveolar cells Pro
Cx43 Testis Sertoli cells Pep
Ovary Granulosa cells Pro
Cx43 Adrenal Spongiocytes Mi
Testis Leydig cells Tes
Ovary Thecal cells An
Luteal cells Pro
Pituitary gland Prolactin cells Pro
Basophil cells AC
Placenta Throphoblast cells B-h
Thyroid C cells Cal
Parathyroid Principal cells Par
Cx36 Pancreas h-cells Ins
Hypothalamus Neurons Gn
Adrenal Chromaffin cells Epi
Cx32 and Cx43 and Cx26 Thyroid Follicular cells Thy
Cx43 and Cx26 Pituitary gland Acidophil cells Gro
Cx26 Pineal gland Pinealocytes Me
Hypothalamus Neurons Gn
Pituitary gland Acidophil cells GH
Cx40 Kidney Myoepithelial cells Ren
Cx43 Sebaceous glands Sebocytes DeGja9 gene has led to the identification of a promoter region
sufficient to restrict the expression of the cognate connexin
to the insulin-secreting h-cells and neurons [12]. Within this
regulatory region, a conserved neuron-restrictive silencer
element binds the NRSF/REST factor, which functions as a
potent repressor of neuronal genes. NRSF/REST is widely
expressed in most cell types, except h-cells and most
neurons, and its ectopic expression reduces that of Cx36 in
an insulin-producing cell line [12]. Thus, endocrine cells and
secretory neurons lacking REST can produce a Cx36
mRNA, whereas most other cells, including numerous types
of gland cells, cannot. In a parallel study, mice lacking the
basic helix–loop–helix transcription factor Mist1, which is
normally expressed in most exocrine cell types, were shown
to feature altered architecture and function of pancreatic
acini, as well as a severe transcriptional down-regulation of
the Gjb1 gene [13]. Strickingly, the acinar cells of Mist1
KO mice were fully uncoupled, due to loss of Cx32 and to
a prominently cytosolic localization of Cx26 [13]. These
findings are at variance with those made in the Cx32 KO
mice, whose pancreatic structure was normal, and acinar cell
coupling as well as membrane localization of Cx26 were at
least partly preserved [24]. These findings point to
transcription as a key step in the differential choice that
secretory cells make between various connexin isoforms.
An additional regulatory event is suggested by the altera-
tions in the levels of several connexins, which are frequentlyretory product Mode of secretion
enzymes (amylase, . . .), ions Exocrine
s, (glyco)proteins
e salts, proteins, cholesterol, . . .
drochloric acid, intrinsic factor
ymes (amylase), ions, bicarbonate
teins, immunoglobulins, ions
tides
teins, immunoglobulins, ions
tides
teins, ions
neralocorticoids, glucocorticoids, androgens Endocrine
tosterone
drogens
gesterone
lactin
TH
CG, hCS
citonin
athormone
ulin
RH, TRH, somatostatin, GH, GHRH, PIH, PRF, ADH
nephrine, norepinephrine
roxine, triiodothyronin
wth hormone, prolactin
latonin
RH, TRH, somatostatin, GH, GHRH, PIH, PRF, ADH
, Prl
in
ad cells, pheromones, complex lipids, . . . Pheromone
Fig. 4. Pancreatic acinar cells are extensively coupled in the resting state and
uncouple during stimulation by secretagogues. (A and B) Microinjection o
Lucifer Yellow revealed that acinar cells are all dye coupled to each othe
within a resting pancreatic acinus. (C and D) Upon stimulation by a
secretagogue, the tracer was retained by the injected cell, indicating uncoupling
of the acinar cells. Scale bar, 15 Am.
L. Michon et al. / Biochimica et Biophysica Acta 1719 (2005) 82–10186observed after the selective deletion of only one of their coding
genes. Thus, mice lacking Mist1 not only showed decreased
transcription of the Gjb1 gene but also decreased levels of the
Cx26 protein [13], indicating a differential transcriptional,
translational and/or post-translational control of 2 connexins,
that are co-expressed by a very same cell type. Similarly,
deletion of the Gjb1 gene resulted in altered membrane levels
of Cx26 in liver hepatocytes [23], acinar cells of pancreas [24]
and lacrimal glands [25], which all normally co-express Cx26
and Cx32 [11]. Thus, some stringent, still to be defined
mechanism links the expression of these beta type connexin
isoforms in various tissues.
3. Gap junctions and exocrine secretion
Forty years after the first identification of dye coupling
between the cells of an exocrine gland [26], an event that
undoubtedly gave a novel, since uninterrupted impetus to the
field of gap junctions and coupling, no multicellular exocrine
gland has been found in which secretory cells are not joined by
connexin channels [2,5,7,9,11]. The following sections, ar-
ranged as a function of the connexin isoform expressed in
various glands (Table 1), summarize the present status of our
knowledge on the effect of the signaling dependent on these
connexins on exocrine secretion. Cx26, Cx32, Cx40, Cx43 and
Cx45 have been reported in exocrine glands after analysis of
either total RNA or proteins [2,11]. However, immunolabeling
of sections has consistently shown that the latter three proteins
are restricted to vessels, connective tissue, contractile cells and
excretory ducts. Thus, only Cx26 and Cx32 are expressed by
parenchymal secretory cells, most of which co-express both
gap junction proteins.
3.1. Cx26 and Cx32
Analysis of transgenic mice deleted for either one of these
proteins [27,28] indicated that neither Cx26 nor Cx32 are
obligatory for a normal prenatal development of exocrine
glands, and for the close to normal differentiation of their
main secretory cells [27,28]. However, recent data indicate
that this conclusion may not hold true, at least in the case of
the mammary glands, when Gjb2 is deleted in the post-natal
period [29]. Furthermore, transgenic animals lacking Cx26
and/or Cx32 show impaired function of many glands
[24,25,27,28].
3.1.1. Pancreas, acinar cells
The acinar cells of pancreas, which secrete a mixture of
about 20 (pro)enzymes, including the predominant amylase,
are coupled by Cx32- and Cx26-made channels [11]. Loss
of Cx32 in transgenic mice had no effect on acinar
architecture, but increased basal amylase secretion, presum-
ably as a result of a decrease in the basal cell-to-cell
coupling [24]. Thus, whereas virtually all cells are coupled
within resting acini of control mice [7,30], this coupling
decreased by more than 60% in acini of knock-out Cx32
animals [24]. Strikingly, the maximal stimulation of thissystem by physiologic cholinergic stimuli, normally results
in at least a partial uncoupling of the acinar cells [7,30]
(Fig. 4). Accordingly, the amylase release measured under
such conditions was similar in control mice expressing
native levels of Cx32 and in knock-out animals that lacked
this protein [24,30]. In the latter animals, some reduction in
the levels of Cx26, which presumably accounted for the
residual coupling of acinar cells, was also detected after loss
of Cx32 [24], suggesting some link in the expression of the
two gap junction proteins. A recent study has provided
some insight about the regulation of this link. Thus, mice
lacking the transcription factor Mist1 showed defective dye
and electrical coupling of acinar cells due to complete loss
of transcription of the Gjb1 gene [13]. Strikingly, and in
spite of a normal transcription of the Cx26 mRNA, the
cognate protein was no more detected in the acini of the
knock-out mice [13]. These studies point to a dual role of
Cx26 and Cx32 in ensuring the coupling of acinar cells
(both protein contribute), to an essential role of Cx32 in the
control of basal enzyme secretion (Cx26 cannot substitute
for this function), and a differential regulation of the
expression of the two gap junction proteins, which are
usually co-expressed by the very same acinar cells.
3.1.2. Lacrimal glands, acinar cells
The acinar cells of the exorbital lacrimal glands, which
secrete the various components of tears, are also coupled by
Cx32 and Cx26 channels [31]. Again, in this system, loss of
Cx32 in transgenic mice altered the distribution of Cx26,
which appeared retained in the cytosolic compartment off
r
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correlated with the persistence of acinar cell coupling in male
but not female animals, and with an abnormally low fluid
output of the glands of female mice, after stimulation by
topical doses of carbachol, in spite of a normal protein
content of the lacrymal secretion [25]. The data suggest a role
of gap junctions in fluid secretion, consistent with previous
findings in another exocrine system [32]. They also imply
that knock-out mice, and specifically female, should be much
more prone to develop corneal erosions and ulcers after loss
of Cx32. So far, this implication has not been documented.
3.1.3. Liver, hepatocytes
Hepatocytes, which secrete the various components of bile,
are coupled by gap junctions containing Cx26 and Cx32 [11],
even though the relative abundance of the 2 proteins varies in
centrolobular and periportal cells [33]. Mice knock-out for the
Gjb1 gene also showed decreased expression of Cx26 at the
hepatocyte membrane [23]. The absence of Cx32 and/or the
mis-localization of Cx26 altered the hepatic function of Cx32-
deficient mice. Thus, after stimulation of the hepatic nerves, the
liver of these animals released significantly less glucose from
glycogen than that of wild type littermates [28]. Moreover,
electrical stimulation of hepatic nerves also resulted in a
reduced bile flow in Cx32-deficient mice [23], a function in
which Cx43, the connexin isoform that couples the cells of
intra- and extra-hepatic biliary ducts may also play a significant
role [34]. In vitro, transfection of a Cx32 cDNA improved the
dye coupling of the hepatoma-derived HepG2 cells, and
enhanced liver-specific functions, such as albumin secretion
and ammonium removal [35]. All together, these results show
an important role of Cx32 in the secretory function of
hepatocytes. The role of Cx26 in this context appears less
relevant, inasmuch as this connexin isoform cannot substitute
for lack of Cx32 [23,28]. However, Cx26 is deemed to have
other essential roles in the functions of hepatocytes, e.g., in the
control of their proliferation [36].
3.1.4. Stomach, parietal cells
Cx26 and Cx32 are co-expressed in the HCl and intrinsic
factor producing parietal cells of gastric glands [37]. Cx32 is
mainly detected at the cell membrane, whereas Cx26 is mostly
localized in the cytoplasm [37]. Inhibition of cell-to-cell
coupling by 18alpha-glycyrrhetinic acid inhibited the increase
in cytosolic-free Ca2+ which is normally caused by gastrin
stimulation, suggesting a physiological role of gap junction
channels in the rapid onset of acid secretion [37].
3.1.5. Salivary glands, acinar cells
The acinar cells of submandibular and sublingual glands,
which secrete the various components of saliva, are also
coupled via Cx26 and Cx32 channels [2,11], which mix within
the same gap junction plaques [38,39]. So far, however, only
circumstantial evidence suggests a role of gap junctional
communication in the secretion of saliva. Thus, cholinergic
stimuli induce in vitro a rapid increase in cytosolic-free Ca2+
and salivary secretion from rat mandibular glands, two eventswhich are inhibited by octanol in both the intact isolated gland
and acini dispersed thereof [40]. The data suggest that gap
junction channels may control salivary secretion via the
inhibition of capacitative Ca2+ entry.
3.1.6. Mammary glands, alveolar cells
Contrasting with the exocrine glands mentioned above, the
alveolar cells of mammary glands express Cx26 and Cx32
[41,42], as well as Cx30 [16] (Table 1). The expression of
the 2 former proteins changes as a function of the
development and function of mammary glands [41,42]. Thus,
Cx26 is barely detectable in the glands of virgin animals,
increases during the early steps of pregnancy and is seen at
steady, maximal levels throughout lactation. In contrast, Cx32
is not detectable in glands of virgin and pregnant rodents, but
is dramatically induced after delivery [16,41,42]. In a variety
of transgenic mice, normal mammary development was
observed after loss of Cx32 or full replacement of this
protein by Cx43 [30], consistent with the observation that
these animals can at least sustain the minimal requirements of
milk production, content and release which are needed to
raise a litter. In contrast, mice in which the Gjb2 gene was
specifically ablated in the mammary epithelium before
puberty, featured abrogated alveolar development and in-
creased cell death during pregnancy, resulting in impaired
lactation [43]. This alteration was developmentally controlled,
inasmuch as it was not observed when Cx26 was ablated
during the later part of pregnancy [30]. Interestingly, Cx32
was reported to initially organize with Cx26 into heteromeric
hemichannels, and to form both heteromeric (Cx26–Cx32)
and homomeric channels (Cx32–Cx32) only at later develop-
mental stages [43], a change which was paralleled by
differences in the cell-to-cell transfer of second messengers
implicated in milk production [43]. Strikingly, channels made
exclusively or predominantly of Cx26 were inhibited by
taurine, an osmolyte accumulating in mammary cells during
lactation and which is required for milk synthesis [43]. The
data indicate that the stoichiometry of connexins in gap
junction channels changes as a function of mammary gland
development, presumably to maximize the specific molecular
and electrical exchanges which are needed to support proper
milk secretion.
3.1.7. Testis, Sertoli cells
A few gap junctions containing Cx26 and Cx32 have been
described in spermatids and Sertoli cells of the seminiferous
epithelium [44].
3.2. Cx30, Cx37, Cx43 and Cx453.2.1. Mammary glands, alveolar cells
Cx30 has recently been reported to be expressed by the
alveolar cells of mammary glands, at levels which increased
during pregnancy and reached a maximum at the onset of
lactation [16]. In agreement with these findings, the expression
of Cx30 was induced in vitro by lactogenic hormones [16].
Even though transgenic mice knock-out for the Gjb6 gene and
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no lactation defect was investigated or reported.
Levels of Cx43 varying with developmental and functional
stages have also been reported in the mammary gland. Thus,
Cx43 was barely expressed in virgin mice, increased from
pregnancy to lactation and, then, decreased with the gland
involution [16,46,47]. These changes further correlated with
post-translational modification, inasmuch as the protein is
mostly non-phosphorylated in the glands of virgin and
pregnant females but is essentially phosphorylated in lactating
animals [16,46,47]. Still, the presence of Cx43 in the
mammary glands does not contradict its usual absence
between the secretory cells of exocrine glands, inasmuch as
the protein is exclusively found in the myoepithelial cells, the
contractile cells which surround the alveolae and the
excretory ducts [46]. Such a localization is in agreement
with the presence of Cx43 in many types of contractile cells
[48], as well as its detection in other ductal, excretory systems
of exocrine glands [34].
3.2.2. Testis, Sertoli cells
Glands such as testis and ovary, which comprise cells
fulfilling both an exocrine (secretion of fluid within the lumen
of seminiferous tubules and the autrum of ovarian follicles,
respectively) and endocrine function (production of testoster-
one, and of androgens and progesterone, respectively) express
mostly Cx43. Cx43 couples Sertoli cells to spermatogonia
and spermatocytes [49,50] as well as to basal germ cells [51].
This connexin appears required for the synchronization of
local functions of Sertoli cells, presumably controlling
spermatogenesis [52]. Accordingly, mice lacking Cx43,
feature at birth unusually small gonads, due at least in part
to a deficiency in the prenatal expansion of the germ cell line
[21,50,53]. Grafting of fetal testis from mice lacking Cx43
under the kidney capsules of wild type SCID mice, revealed
that this defects persisted postnatally [53].
3.2.3. Ovary, granulosa cells
The granulosa cells of the ovarian follicle have been
reported to be mostly coupled by Cx43 gap junctions [54–
57], even though expression of Cx32, Cx37 and Cx45 have
also been documented [58–60]. The relevance of the Cx43
role is demonstrated by the abnormal postnatal folliculogen-
esis in mice lacking this isoform [50], and by the delayed
growth of oocytes in follicles showing reduced [61] or nil
levels of Cx43 [62]. Cx37 channels are restricted to the
interface between the oocytes and the granulosa cells forming
the cumulus [60]. This connexin also plays a major role in the
functional development of ovaries, inasmuch as mice lacking
Cx37 feature a premature interruption of follicle development
and oocytes which cannot complete their normal meiotic
maturation [60].
4. Gap junctions and endocrine secretion
In vertebrates, the hormone-producing cells of all multicel-
lular endocrine glands are also connected by functional gapjunctions. The reason for this apparently obligatory require-
ment is presumably related to the functional heterogeneity of
individual cells, which differ within a very same gland in
several respects, including the ability to biosynthesize, store
and release hormones [63–66]. Recent work further indicates
that connexins are also essential to ensure the accurate
synchronization of cell events, which is required to release
the hormones in a regularly, rhythmic burst pattern, that should
follow specific frequency and circadian rhythms to avoid over
effects and run-down of the peripheral receptors [67–71]. To
achieve the proper cell-to-cell communication that underlies
these functions, most endocrine cells have utilized Cx43 (Table
1), the connexin isoform which, as summarized above, has
usually been excluded by the parenchymal cells of exocrine
glands. In the endocrine glands, Cx43 either expressed alone,
providing for only homomeric and homotypic channels, or is
co-expressed with other connexin isoforms, usually Cx36 and
Cx40, leading to the possibility of at least some type of
heteromeric and/or heterotypic channels (Cx43–Cx40). In a
few endocrine glands, that embryologically originate as
exocrine adnexae to epithelia, an unusual situation is found
in which Cx32 and Cx26 are co-expressed with Cx43 by the
very same secretory cell [2,3,11], even though not in the same
membrane compartment. Under these circumstances, the gland
may be endowed with a variety of rather different homomeric
channel types.
4.1. Cx43
4.1.1. Adrenal gland, cortex spongiocytes
Cx43 is expressed by the spongiocytes of the adrenal
cortex, which produce corticoids and sexual hormones
[11,72–77]. The abundance of gap junctions varies in the
different regions of the cortex. Thus, whereas there is little
or no Cx43 in the outer, mineralocorticoid-producing region
(zona glomerulosa), the protein is abundant in the inner
glucocorticoid- (zona fasciculata) and androgen-producing
regions (zona reticularis) [72,73]. This distribution correlates
with regional differences in dye coupling, which is barely
detectable in the outer region and conspicuous in the inner
regions [76]. The number and size of gap junction plaques
increased in bovine adrenal cortical cell lines [74] and
primary rat adrenal cortical cells [75] after exposure to
ACTH, the predominant hormone in the physiologic control
of steroidogenesis. Conversely, drugs blocking Cx43 chan-
nels and antisense constructs decreasing their numbers,
impaired the ACTH-induced secretion of cortisol in vitro
[74,76,77]. Eventually, Cx43 was found decreased in the
inner cortical regions of adrenal glands of hypophysecto-
mized mice, and was restored at about normal levels when
the animals were treated with ACTH, indicating a rapid and
direct hormonal regulation of the in vivo assembly of Cx43-
made gap junctions [78]. However, potentially conflicting
results have been recently published with regard to the Cx43
induction by exogenous ACTH, since the infusion of this
hormone in sheep adrenal glands decreased Cx43 expression
[79]. Furthermore, the effect of gap junction blockade on
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alpha-glycyrrhetinic acid, which stimulated this anabolic
pathway by a mechanism distinct from the protein kinase
A-dependent one which physiologically controls steroido-
genesis of adrenal cells [80]. Future studies should carefully
address whether these apparently contradictory observations
reflect a difference in the animal, cell model or experimental
protocol tested in various studies. At any rate, the
mechanism whereby gap junctions and/or cell coupling
may be implicated in steroidogenesis remains to be
elucidated. The finding that the production of cAMP
increases in cortical cell lines after ACTH exposure, and
that an experimental elevation in the cytosolic levels of
cAMP reproduces in these cultures the steroidogenic
induction as well as the increase in gap junction plaques
observed with ACTH implicates the cyclic nucleotide in the
regulatory pathway triggered by Cx43 [74].
4.1.2. Testis, Leydig cells
Even though six connexin transcripts have been reported
to be expressed in the testis [81–83], the testosterone-
producing cells of Leydig [84–86] appear mostly coupled
by Cx43-made gap junctions [45,82–84], which decrease in
confluent cell cultures, presumably as a result of activation
of pathways dependent on protein kinase A and C [85]. A
comparable decrease was observed during LH-induced
stimulation of testosterone production, suggesting a tonic
inhibitory influence of the connexin signaling [85]. In
agreement with these observations, stimulation of testoster-
one production by hCG was also associated with a decrease
in Cx43 mRNA levels both in vitro and in vivo [86]. This
effect was mimicked by cAMP [86], suggesting that this
second messenger somehow links the connexin-dependent
signaling to the production of testosterone.
4.1.3. Ovary, thecal and luteal cells
The thecal cells of the ovarian follicles, which produce
androgens, are connected by Cx43 [54,55,60]. The expression
of this connexin varies with the stage of follicle development,
consistent with an involvement of connexins in the endocrine
function of thecal cells [56,57,87]. Conversely, the expression
of follicular Cx43 appears to be under a tight hormonal
control. Thus, treatment of hypophysectomized rats with
estrogens up-regulated Cx43 expression, whereas treatment
with gonadotropins, which stimulated ovulation and the
formation of corporea lutea, down-regulated it [88]. More-
over, Cx43 levels were shown to decrease after the ovulatory
LH surge [88].
The cells of corporea lutea, which produce progesterone,
are also coupled by Cx43 [89,90]. Pharmacological treatments
enhancing this coupling increase progesterone production,
whereas treatments uncoupling luteal cells decrease steroid
production [54]. Consistent with a relationship between
connexin signaling and steroid production, the experimental
inhibition of Cx43 expression decreased the LH-induced
steroid production of luteal cells [91]. Strikingly, mice lacking
Cx37, the connexin that forms gap junctions between oocytesand granulosa cells, also developed numerous and abnormal
corpora lutea, by a mechanism which has not yet been
elucidated [60].
4.1.4. Anterior pituitary, prolactin-producing cells
In rodents, Cx43 couples several endocrine cell types
within the anterior pituitary [11,92–95]. This coupling
increases the intercellular synchronization of Ca2+ transients
[96]. Ca2+ waves are also propagated throughout the entire
gland via the network of folliculo-stellate cells that are
extensively coupled by Cx43 channels [94,97]. Annual
screening of minks showed that the levels of Cx43 and the
number of gap junction increased in the anterior pituitary
during period of high prolactin content, under which
conditions, the cellular distribution of the connexin was
modified [98].
4.1.5. Placenta, cytotrophoblast cells
Cx43 connects the cells of placental cytotrophoblast, and
these cells to those of the syncytio-trophoblast [99–101].
Recent studies have reported that the pharmacological block-
ade of gap junctions, as well as the antisense interference with
the Cx43 transcript, uncouple cytotrophoblast cells, impairing
their fusion and, thus, the formation of the syncytio-trophoblast
[102,103]. These alterations were associated with a decrease in
both the expression of trophoblast-specific genes, including
those coding for h-hCG and human chorionic somatotropin
[102,103], and the secretion of the former placental hormone
[103].
4.1.6. Sebaceous glands, sebocytes
Pheromone glands, which are the phylogenetic precursors
of multicellular endocrine systems, combine an exocrine
mode of secretion with chemical signaling typical of
hormones [2,3]. So far, Cx43 is the only connexin, which
has been described in a pheromone-producing gland of
rodents [11], as well as in the sebaceous glands of skin that
represent their human homologs [104]. Whether Cx43 plays
any role in the secretion of volatile pheromones has not yet
been investigated.
4.2. Cx36
4.2.1. Pancreas, b-cells
Cx36 channels couple the insulin-producing h-cells of
pancreatic islets [105–107] (Fig. 5) at sites of minute gap
junctions [108]. Contrasting with most other types of cells, h-
cells have not been convincingly shown to express other
connexin isoforms, at least in normal adult rodents [109].
While it is not questionable that a Cx43 transcript is
consistently found in pancreatic islets [105,109], the present
evidence points to an endothelial and fibroblastic, rather than
endocrine cell localization of the cognate protein [109].
However, a couple of reports have suggested that some
induction of Cx43 may occur under certain conditions
[110,111]. However, until such an induction can be documen-
ted in vivo, the available in vitro data should be evaluated in
Fig. 5. Pancreatic h-cells are coupled in the resting state and do not uncouple
during stimulation by secretagogues. (A) Microinjection of Lucifer Yellow
revealed that small groups of h-cells are dye coupled within a resting pancreatic
islet of Langerhans. (B) Upon stimulation by a secretagogue, the tracer was still
transferred between several coupled cells which, as quantitated in serial
sections of islets, were usually more numerous than under basal condition. (C)
Such a transfer was not observed in an islet isolated from a homozygous KO-
Cx36 mouse, demonstrating that h-cell coupling is mediated by Cx36 channels.
Scale bar, 45 Am.
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the ectopic expression of Cx43, which most cells face when
exposed to standard culture conditions. The functional impor-
tance of Cx36 is demonstrated by the impairment of glucose-
induced insulin secretion and of its causal calcium waves after
transfection of both primary h-cells and insulin-producing cell
lines with Cx36 antisense constructs [112–116] or cDNA
coding for other connexin species [22,115]. Recently, these
observations have been extended to the in vivo situation. Thus,
h-cells of knock-out transgenic mice lacking Cx36 were
uncoupled (Fig. 5) and failed to respond to glucose stimulation
with regular and synchronized calcium waves [67]. As a result,
islets lacking Cx36 did not release insulin in a normal pulsatile
fashion, and showed an increased basal release of insulin [67].
These pancreatic alterations are similar to those which are
observed in type II diabetics [1–3,67], and indicate that loss of
h-cell coupling alters insulin secretion. Strikingly in vitro
experiments indicate that adequate levels of Cx36 are required
for proper insulin secretion. Thus, the excess of Cx36 appears
as deleterious as the lack of the connexin for proper insulin
secretion [114,115].
4.2.2. Hypothalamus, neuroendocrine cells
Many types of secretory neurons are also coupled by
Cx36 [117–120], which is one of the many proteins that are
specifically shared by neurons and pancreatic h-cells [12].
Electrophysiological studies testing gap junction blockers
have indicated that this coupling is implicated in the controlof the pulsatile release of several neuropeptides, including
GHRH [68], GnRH [69] and LHRH [70].
4.2.3. Adrenal gland medulla, cathecolamine-producing cells
Cx36 is expressed by the chromaffin cells of the adrenal
gland medulla [71,106,107], which release catecholamines.
Studies in rats demonstrate that the signaling dependent on
Cx36 controls the basal release of both epinephrine and
norepinephrine [71] and amplifies it after nicotinic stimulation
by a cholinergic-dependent mechanism [121].
4.3. Cx32
Cx43, Cx32 and Cx26 are coexpressed in rodent thyroid
glands [11,122–124]. In vitro, exposure of primary thyrocytes
to TSH increased dye coupling in a time- and dose-dependent
manner [124], whereas a mutation of Cx32 which leads to
uncoupling, decreased thyroxine release [125]. Moreover,
forced expression of Cx32 in a communication-incompetent
thyroid cell line induced the up-regulation of the thyroglobulin
gene [126]. Strikingly, however, the production of thyroxin
was found unaffected in fetuses of Cx43/Cx32 double knock-
out mice [127], indicating that the in vitro effects of connexins
on thyroid function may not necessarily reflect the in vivo
relevance of the connexin-dependent mechanisms. Presumably,
this indicates that compensatory mechanisms enter into the
play, in order to sustain a vital secretory function in the absence
of the connexin regulation.
4.4. Cx26
Beside the case of the thyroid gland mentioned in the
previous paragraph, a few other endocrine glands have been
shown to express Cx26.
4.4.1. Pineal gland, melatonin-producing cells
Pinealocytes have been reported to be coupled by Cx26
channels, which are up-regulated in vitro by norepinephrine,
possibly to improve melatonin secretion [14].
4.4.2. Anterior pituitary, GH- and PRL-producing cells
The acidophile cells of the anterior pituitary, which
produce growth hormone and prolactin, are coupled [92–
95] via channels made predominantly of Cx43 and Cx26
[11,92]. While there is some evidence for a secretion
modulatory role of Cx43 (see above Section 4.1.4), the
specific function of Cx26 in the function of the pituitary
remains to be established.
4.4.3. Hypothalamus, neurosecretory neurons
GnRH-secreting cells express Cx36 [128], the only con-
nexin which has yet been unambiguously mapped to the gap
junction connecting neurons [129]. However, these cells have
been reported to also express Cx32, Cx43 and Cx26 in situ
[130], and Cx26 is the predominant connexin isoform coupling
the GnRH-secreting cells of the GT1 line [15]. These cells
feature a synchronized release of the hormone only when
Table 2
Connexins of exocrine and endocrine glands
Type of secretion Organ Cell type Secretory product Connexin
Enzymes Pancreas Acinar cell Amylase, lipase and other Cx26
digestive enzymes Cx32
Salivary glands Acinar cell Amylase, lipase Cx26
Cx32
Prostate Alveolar cell fibrinolysin, other Cx26
enzymes, peptides Cx32
Milk Mammary glands Alveolar cell Casein, immunoglobulins, Cx26
other proteins, lipids, ions Cx30
Cx32
Bile Liver Hepatocyte Biliary salts, proteins, Cx26
bilirubin, ions Cx32
Fluid Salivary glands Acinar cell Water, ions Cx26
Cx32
Lacrymal glands Acinar cell Water, ions, peptides, Cx26
(glyco) proteins Cx32
Stomach Parietal cell Water, intrinsic factor, Cx26
HCl, HCO3
 Cx32
Pancreas Acinar cell Water, ions Cx26
(in rodents) Cx32
Duct cells Water, ions Cx45 ?
Ovary Granulosa cell Water, ions, glycoproteins Cx37
Cx43
Testis Sertoli cells Water, ions, inhibin, activins, . . . Cx43
Mucus Salivary glands Acinar cell mucins Cx26
Cx32
Sugars Liver Hepatocyte Glucose Cx32
Cx26
Seminal vesicle Alveolar cell Fructose, peptides, prostaglandins Cx26
Cx32
Peptide hormones Heart Auricular Atrial natriuretic hormone Cx43
myoendocrine cell Cx45
Pancreas h-cell Insulin Cx36
a-cell Glucagon Cx36 ?
Cx43 ?
Thyroid C cell Calcitonin Cx43
Parathyroid Chief cell Parathormone Cx43
Anterior pituitary Acidophil cell Growth hormonel Cx43
Prolactin Cx26
Posterior pituitary Oxytocin, Vasopressin Cx36
Hypothalamus Neuroendocrine cell Gonadotropin releasing hormone,
Corticotropin releasing hormone,
Thyrotropin releasing hormone,
Growth hormone releasing hormone,
Somatostatin
Cx36
Prolactin release inhibiting hormone,
Prolactin releasing factor, . . .
Cx26 ?
Indolamine hormones Pineal Pinealocyte Melatonin Cx26
Serotonin
Glycoprotein hormones Kidney Myoepithelial cell of
afferent arteriole
Renin Cx40
Thyroid Follicular cell Triiodothyronine, Cx43
Thyroxine Cx32
Cx26
Anterior pituitary Basophil cell Follicle stimulating hormone; Cx43
Luteinizing hormone;
Thyroid stimulating hormone;
Adrenocorticotropic hormone
Placenta Throphoblast cell Human chorionic gonadotropin, Cx43
Human chorionic
somatomammotropin
Steroid hormones Adrenal cortex Spongiocyte Corticoids, Cx43
Mineralocorticoids,
Androgens
(continued on next page)
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Type of secretion Organ Cell type Secretory product Connexin
Testis Leydig cell Testosterone Cx43
Steroid hormones Ovary Thecal cell Androgens Cx43
Luteal cell Progesterone Cx43
Cathecolamines Adrenal medulla Chromaffin cell Epinephrine, Norepinephrine Cx36
Pheromones Skin Sebaceous cells Sebum components Cx43
Preputial glands Alveolar cells Farnesenes, other lipids Cx43
Table 2 (continued )
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providing some clue that gap junctions are involved in the
pulsatile release of the hormone. A single patient affected by
congenital deafness because of a Cx26 mutation has so far been
documented with a form of hypogonadotrophic hypogonadism
of hypothalamic origin [130]. Thus, until additional cases are
documented, the endocrine disorder reported in this study
cannot be considered more than an associated phenotype.
4.5. Cx40
In kidneys, the renin-producing cells are joined to each other
by Cx40 gap junctions, which also connect these endocrine
cells to nearby endothelial cells [131]. Rats made hypertensive
after clipping of one renal artery, showed a selective increase in
kidney renin and Cx40, implying that the connexin is involved
in the control of renin secretion and/or in the vasomotor control
of kidney vessels [131]. However, in a strain of spontaneously
hypertensive rats, Cx40 was found decreased between the
endothelial cells of digestive arteries, and the pharmacological
blockade of the renin-angiotensin system increased the levels
of the protein while decreasing the hypertension [132,133].
These studies concur to indicate a link between the Cx40-
dependent signaling and renin secretion, but also point to a
different impact of the connexin pathway in renin-dependent
and -independent forms of hypertension.
5. A gland-based view of connexin distribution
Table 2 revisits the distribution of connexins as a function of
the type of exocrine and endocrine secretion. When compared
to Table 1, which focuses on connexin isoforms, Table 2 shows
that the selection of these isoforms does not directly relate to
the biochemical nature of the main product of each gland, the
rate of its secretion and the type of control of its release and
biosynthesis. This selection is also not immediately linked to
the embryological origin of the glands, the chronology of their
development and/or their adult architecture. The organ-based
classification further outlines that the main secretory cells of
most exocrine and endocrine glands express multiple connex-
ins, with the notable exception of gland cells connected by
Cx36 that usually do not use any other additional connexin
species (Table 2). Eventually, the organ-based classification
stresses the notion that most exocrine cells use in combination
multiple connexins of the h group, whereas most endocrine
glands use a single connexin of either the a or the g group [11].
Since the main function of glands is the regulated
biosynthesis, storage and release of secretory products,particular attention has been taken to relate the expression of
connexins and/or the extent of the cell-to-cell communications
these proteins permit to these secretory parameters. The data
gained on this respect in various glands are summarized in the
following sections.
5.1. Enzyme-producing glands
5.1.1. Pancreatic acinar cells
The deletion of the Gjb1 gene, which encodes Cx32,
increases the basal secretion of amylase from pancreatic acinar
cells, in spite of the retained expression of Cx26 and of a
reduced coupling [24]. These changes were associated to an
increase in the circulating levels of the digestive enzyme,
providing direct evidence that Cx32 significantly affects the in
vivo functioning of the gland [24]. These findings are
consistent with the previous observations that pancreatic acinar
cells are extensively coupled under resting conditions but
rapidly uncouple during maximal stimulation [7,30], and that
pharmacological blockade of coupling increases amylase
release in the absence of other secretagogues [140]. Thus,
acute uncoupling of acinar cells is somehow required to
initiate, maintain or enhance the increased secretion of
pancreatic enzymes which is elicited by endogenous hormones
and neurotransmitters, as well as by agonist drugs.
Since the secretagogues that uncouple acinar cells increase
cytosolic-free Ca2+ levels and induce waves of the cation whose
intercellular propagation and frequency are at least partly
dependent on gap junction channels [141–143], the secreta-
gogue-induced uncoupling presumably takes place after the
initiation of the agonist stimulation. The persistence of coupling
at the beginning of this stimulation allows for the transmission of a
threshold signal produced in few acinar cells to all other cells of
each pancreatic acinus, thus ensuring the functional recruitment of
many additional secreting cells [64]. The subsequent uncoupling
may be needed to terminate the agonist action, as indicated by the
decrease in the junctional conductance of acinar cell pairs after the
agonist-induced Ca2+ peak [144]. However, it is equally possible
that some of the endogenous molecules that permeate connexin
channels may negatively control the secretion of enzymes
produced by acinar cells (Fig. 6). By hindering the intercellular
exchange of these signals, uncoupling could then allow for a
number of acinar cells to escape inhibition and enter activated
secretion. Eventually, uncoupling may be needed to functionally
isolate those acinar cells that are highly sensitive to secretagogues,
in order to prevent the dilution of the agonist-induced second
messengers into less sensitive cells of the acinus [64,144]. It has
indeed been shown that, when exposed simultaneously to a
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secretory function and that this functional heterogeneity decreases
as acinar cells aggregate and express connexins [64,145].
5.1.2. Salivary acinar cells
The connexin involvement in salivary secretion appears
similar to that of pancreas. Thus, individual cells of the
major salivary glands show a heterogeneous function [146],
become uncoupled within the acini during stimulation by
cholinergic agonists [7,147] and show inhibited secretion
after drug-induced uncoupling [40]. However, the specificity
of the latter effect remains to be determined, inasmuch asthe alkanol used to cause uncoupling also inhibited the
capacitive entry of Ca2+ into acinar cells [40]. The use of
knock-out transgenic mice lacking one or another of the
connexins connecting the acinar cells of salivary glands
[11,38,39] should allow to address this question.
5.2. Milk-producing glands
The alveolar cells of mammary glands change the
expression of Cx26, Cx30 and Cx32 as a function of theirFig. 6. Working model of the contribution of connexins to secretion. Based on
the data gathered in the exocrine and endocrine pancreas, a working model can
be proposed to account for the connexin–secretion relationships that have been
experimentally observed. (A) In glands made of functionally heterogeneous
cells (left panel) that either lack gap junctions or in which connexin channels
are blocked, stimuli activate only those cells that feature adequate levels of
relevant receptors and second messengers acting as either positive (black dots)
or negative regulators of secretion (red dots). Establishment of gap junctional
communication (right panel) permits the diffusion-driven passage of these
critical ions and molecules between the coupled cells and, at steady state, their
equilibration. The resulting increase in positive regulators, and/or decrease in
negative regulators, could account for the recruitment of increasing numbers of
secretory cells that is observed with cell aggregation and coupling of both the
acinar and islet cells of pancreas. Under these conditions, these cells also
function in synchrony with the companion cells forming a communication
territory within the exocrine acini and the endocrine islets, respectively. (B)
Under resting conditions (left panel), coupling is large between the cells of
pancreatic acini, providing for the equilibration of the signal molecules that
positively and negatively regulate secretion. This equilibration ensures the
secretory recruitment and synchronous function of the coupled cells, leading to
an amylase secretion larger than that observed from uncoupled and single
acinar cells, some of which may not be appropriately equipped to secrete
individually. Acute stimulation by secretagogues (right panel), including the
main physiological neurotransmitter acetylcholine (ACh), provides for the
activation of the secretory machinery of individual cells, which increases the
levels of signals upregulating secretion (black dots). ACh also uncouples acinar
cells, preventing the dilution of these positive regulators, which would reduce
their concentration below the threshold level for stimulation of secretion, and
which would result from their diffusion across the highly permeant Cx26 and
Cx32 channels, and into the large cytosolic volume of coupled acinar cells. As
a result of these two concomitant changes, amylase release is markedly
promoted. (C) Under resting conditions (left panel), groups of pancreatic h-
cells are coupled within each pancreatic islet, providing for only a partial
equilibration of the signal molecules that regulate secretion. As a result, basal
insulin release is higher than that of single (or uncoupled) h-cells. Acute
stimulation by secretagogues (right panel), including the main physiological
nutrient glucose, activates the secretory machinery of most h-cells and, by
increasing their coupling, enhances their Cx36-dependent synchronization. As
a result of these two concomitant changes, insulin release is markedly
promoted. Thus, several factors contribute to the effect of connexins on
secretion, including cell volume, type of connexin isoform, permeability of the
junctional channels to positive and negative regulators of the secretory
machinery, levels of expression of the connexins, extent of the resulting
communication compartment, and effect of secretagogues on the latter.
Conceivably, differences in one or more of these factors account for the
different behaviour of the exocrine and endocrine cells of pancreas, under
resting and stimulated conditions. However, it should be stressed that, until the
endogenous gap junction-permeant molecules (the dots in the figure) are
identified, this model remains at best an academic hypothesis. Also, this model
does not consider additional contributions of connexins, by way of their
interactisms with other proteins, including transcription factors and cytoskel-
eton proteins, that are essential to the control of secretion. As evidence will
become available for such interactions in pancreatic systems, sizable
notification of the present working model may be required.
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ing that precise ratios of these isoforms are required for
proper production and/or storage of milk. So far, however,
only the deletion of the Gjb2 gene, which encodes for Cx26,
has been reported to result in impaired lactation, pointing to
a central role of this connexin at least before pregnancy [29].
The mechanism underlying this role remains to be investi-
gated. Cyclic changes in the levels of Cx43, which links
myoepithelial cells, have also been documented in mammary
glands [16,46,47], suggesting that a connexin-dependent
mechanism is also implicated in the control of cell
contraction [48], which is relevant to the release of milk,
during lactation.
5.3. Bile-producing gland
Pharmacological uncoupling of hepatocytes alters the bile
flow induced by glucagon and vasopressin, respectively,
without affecting basal biliary secretion [149]. Since the
uncoupling treatment did not alter bile flow when the levels
of the second messengers used by the two hormones were
increased across the entire hepatic lobule, the data suggest that
junctional communication is important for the diffusion
towards peri-portal hepatocytes of signals generated in
centro-lobular cells [149]. Accordingly, electrical stimulation
of sympathetic nerves in mice lacking Cx32 lead to an
abnormally low decrease of bile flow, but not of total bile
output, suggesting that the contraction of the bile canaliculi
formed by the hepatocyte membranes is somehow impaired in
the absence of this connexin [23].
5.4. Fluid-producing glands
5.4.1. Lacrymal acinar cells
The deletion of the Gjb1 gene, encoding for Cx32, induced
the uncoupling of acinar cells of exorbital lacrymal glands and
decreased their fluid secretion in response to low, but not to high
doses of carbachol [25]. Intriguingly, this secretory defect was
restricted to female mice and did not affect the resistance of the
cornea of the knock-out animals [25].
5.4.2. Gastric parietal cells
In vitro, the stimulation of the parietal cells of gastric
glands by gastrin increases the permeability of their junc-
tional channels to both Lucifer Yellow and Ca2+, under
conditions that also increase the acid (in the gastric lumen)
and HCO3
 (in the gastric mucosa) release from the same
cells [37].
5.4.3. Pancreatic acini and ducts
The in situ vascular perifusion of pancreas with drugs
blocking connexin channels resulted in a stimulation of the
amylase and fluid secretion from exocrine acinar cells and
ducts, and in a parallel decrease of the insulin secretion from
pancreatic islets, showing the different regulation of coupling
by secretagogues in this mixed exocrine and endocrine gland
[32].5.5. Sugar-producing gland
Livers of transgenic mice lacking Cx32 showed reduced
coupling of hepatocytes [150] and decreased glucose output
in response to noradrenaline and glucagon, as a result of
decreased hydrolysis of the liver glycogen stores [151]. The
latter alteration was not observed when the two stimulating
hormones were infused at saturating concentrations, sug-
gesting that the residual Cx26 channels were able to
propagate both a neural (sympathetic) and a hormonal
signal (possibly mediated by cAMP ?) from peri-portal to
centro-lobular hepatocytes [151].
5.6. Peptide hormone-producing glands
5.6.1. Pancreatic insulin-producing b-cells
Transgenic mice lacking Cx36 comprise uncoupled h-cells
without gap junctions, that fail to show the intercellular
synchronization of [Ca2+]= transients and the pulsatile release
of insulin which are induced during glucose stimulation of
control h-cells [67]. Furthermore, islets lacking Cx36 show an
increased basal release of insulin, accounting for the absence
of a further secretion increase during stimulation by postpran-
dial sugar concentrations [67]. These observations show that
Cx36-dependent signaling is essential for proper regulation of
insulin release in vivo [67], thus extending the observations
previously made after the transgenic expression of the islet-
ectopic Cx32 [22] or in several in vitro models [113–116].
The latter experiments were instrumental to document the
specificity of the secretion control achieved by the Cx36
signaling, and to show that this control requires adequate
amounts of connexin channels [113,115]. These observations
are also in agreement with the findings that several cell lines
featuring defective insulin secretion do not express connexins
[112,113], and that single, uncoupled h-cells show alterations
in the transcription of the insulin gene and in the secretion of
the cognate hormone, which are rapidly corrected after
restoration of h-cell contacts [63,65,66,152], and which are
mimicked by the pharmacological blockade of connexin
channels [153].
Recent in vitro and in vivo data show that the mechanism
underlying these secretory defects is the remarkable depen-
dence of h-cells on Cx36 to synchronize throughout the islets
the glucose-induced oscillations in [Ca2+]i which, in turn,
drive the oscillations in insulin output [67,113]. Glucose
stimulation induces secretory and metabolic responses from
either intact pancreatic islets or clusters of islet cells, which
are markedly more uniform than those of single h-cells [154–
158]. Thus, coupling between pancreatic h-cells appears
essential to synchronize the activity of individual cells which,
taken individually, are metabolically and secretory heteroge-
neous [1,5,6]. Nevertheless, the reason why asynchrony is
deleterious for h-cell function remains to be validated by a
direct experimental testing. Irregular Ca2+ oscillations could
conceivably alter the expression of specific h-cell genes
[158], the resistance of h-cells to apoptosis [136], or other
events [3].
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Using pharmacological gap junction blockers, the coupling
of several hormone-producing neurons has been related to the
control of the pulsatile release of GHRH [68], GnRH [69] and
LHRH [70].
5.6.3. Pituitary prolactin-producing cells
Seasonal changes in the expression of pituitary Cx43 have
been associated to changes in prolactin secretion [98].
5.7. Glycoprotein hormone-producing glands
5.7.1. Thyroid T3- and T4-producing follicular cells
The involvement of connexins in thyroid secretion is
supported by the observation that TSH stimulation increases
the coupling of thyrocytes in a time- and concentration-
dependent manner [124], whereas loss of coupling, due to a
Cx32 mutation, reduces the release of thyroxin [125].
Furthermore, transfection of Cx32 in thyroid-derived cell
lines also resulted in increased expression of the thyroglobulin
gene [126].
5.7.2. Placental-producing cells
The pharmacological blockade of gap junctions as well as
the antisense interference with Cx43 transcripts, which
uncouple the cytotrophoblast cells of the placenta, are
associated with a decrease in the expression of the genes
coding for h-hCG and human chorionic somatomammotropin
[102,103], and with a reduced secretion of the former placental
hormone [103].
5.8. Steroid hormone-producing glands
5.8.1. Adrenal corticoid-producing cells
In vitro, a decrease in the coupling of adrenal cells, as a result
of either the exposure to drugs blocking connexin channels or
the transfection of a Cx43 antisense construct, was paralleled by
impaired ACTH-stimulated release of cortisol [74–76]. How-
ever, another gap junction blocker was recently reported to
stimulate steroid production, via the activation of two pathways
(an extracellular signal-related kinase and a calcium/calmodulin-
dependent kinase) which are distinct from that (protein kinase A-
dependent) which controls steroidogenesis of primary cells [80].
Stimulatory concentrations of the natural stimulatory hormone
ACTH increase Cx43 expression of adrenal cells, in vivo and in
vitro [10].
5.8.2. Testicular testosterone-producing cells
The cells of a testosterone-producing cell line become
partially uncoupled during LH-induced stimulation of testos-
terone secretion, suggesting a tonic inhibitory influence of
connexin signaling on the release of the steroid hormone [85].
5.8.3. Ovarian luteal cells
Consistent with a relationship between connexin signaling
and steroid production, the experimental inhibition of Cx43
expression [91], as well as drug causing uncoupling, decreasedthe LH-induced steroid secretion of luteal cells [54]. Con-
versely, pharmacological treatments enhancing the coupling of
corporea lutea cells were associated with increased progester-
one release [54].
5.9. Cathecolamine-producing glands
The coupling of the chromaffin cells of the adrenal medulla is
enhanced during stimulation of catecholamine release by
nicotine, indicating that a Cx36-dependent signaling amplifies
the secretion of epinephrine and norepinephrine [71]. The
pharmacological blockade of synaptic transmission, as well as
the surgical denervation of the adrenal glands, resulted in
increased coupling of chromaffin cells, indicating that the Cx36-
dependent signaling is tonically inhibited by cholinergic
synaptic inputs [121].
6. A working model of connexin functions
The studies summarized above provide compelling evidence
for a physiologically relevant role of cell-to-cell communication
mediated by connexins in the secretion of a variety of exocrine
and endocrine glands. However, it should be stressed that only in
a few glands has the molecular mechanism underlying such a
role began to be elucidated. Many of the endogenous molecules
that permeate connexin channels are also important signals for
many types of secretion [1,5,7,9,18,19,138], complicating the
identification of the signal(s) that couple the changes in
connexin-dependent communication to the changes in secretion.
The most direct evidence on this respect, is so far available for
only pancreas and the adrenal medulla, and points to a central
role of stimuli-induced Ca2+ transients that require connexin
channels to become synchronized in different cells. However,
recent studies suggest that connexins may control cell function-
ing, and particularly gene expression and cell growth even in the
absence of significant cell-to-cell communication [139]. The
underlying mechanism which may involve the passage of second
messengers through hemi-connexin channels and/or the interac-
tion of connexins with other membrane and cytosolic proteins is
not yet elucidated. At any rate, the reason why connexins
contribute so significantly to the complex signaling network that
controls most secretory processes remains to be understood.
In view of the above, any model regarding the function of
connexins in glands is admittedly highly speculative and
should not be regarded more than a framework on which to
build working hypotheses to be tested by direct experimen-
tation. As compared to other forms of cell-to-cell commu-
nications, which involve the interaction of cells with either
signal molecules (hormones, neurotransmitters, ATP, NO, etc.)
diffusing in the intercellular spaces, or adjacent cells (via cell
adhesion molecules, integrins, etc.), the intercellular commu-
nication mediated by gap junctions is unique in that it is
driven by diffusion and, thus, may achieve a rapid equilibra-
tion of ionic and molecular electrochemical gradients between
coupled cells (Fig. 6). If the resulting concentration of signal
molecules reaches a threshold level for activation (or
inhibition) of an effector mechanism, functioning will be
L. Michon et al. / Biochimica et Biophysica Acta 1719 (2005) 82–10196modified not only in the cell in which the ionic and molecular
change first occurred, e.g., as a result of secretagogue
stimulation, but also in the cells coupled to it. In this case,
junctional coupling could result in the functional recruitment
of cells that, otherwise, may not be directly activated (or
inhibited) [63–66]. In these cases, the secretion of the
coupled cells was actually larger than that which the same
number of cells show when they are isolated from each other,
indicating that coupling also optimizes the levels of the signal
molecules which stimulate the effector mechanisms essential
for xsecretion (Fig. 6). Eventually, the coupling-induced
equilibration of cytoplasmic constituents would be expected
to also synchronize those functions which are modulated by
gap junction-permanent molecules (Fig. 6), an expectation
which as been verified experimentally [67,71,113]. Converse-
ly, uncoupling, as well as the use of connexins imparting to
cell-to-cell channels a selective permeability to certain
cytosolic molecules [18–20,159] could result in the estab-
lishment of specific efslectrochemical gradients (Fig. 6),
which may be beneficial to avoid the dilution of essential
factors regulating secretion in glands where large numbers of
cells are extensively coupled (Fig. 6). Such a dilution could
cause the levels of these molecules to fall below the threshold
level of activation, hence resulting in decreased secretory
outputs (Fig. 6). This pattern has been observed in several
exocrine acinar cells [7,24,30].
These considerations imply that junctional coupling may
be of particular value in tissues comprising of cells with
substantial structural, metabolic or functional heterogeneity.
Increasing evidence shows that such a heterogeneity exists in
may secretory systems [63–66,160–165]. Disparities in
intrinsic structural and functional properties will conceivably
result in the asynchronous function of individual cells (Fig.
6). Junctional coupling could decrease or correct these
localized disbalances, thus permitting distinct cell subpopula-
tions to function simultaneously and/or at the same rate
[67,71,113].
7. Non-secretory functions of gland connexins
While this review has mostly focused on the involvement of
gap junction proteins and coupling in the secretory function of
glands, other roles of connexins should not be undervalued,
which are relevant to the development, morphogenesis, growth,
differentiation, renewal and repair of glands. The ablation of
1–2 connexin genes expressed in secretory systems has usually
shown an apparently normal development of the targeted
glands, implicating that either the connexin-dependent signal-
ing has no essential function in gland development or that,
some in vivo mechanism can fully compensate the lack of this
signaling [28,67,109,127,133], at least in most cases. This
presumably reflects the obligatory requirement of secretory
systems which are essential for life sustainment during both the
pre- and post-natal periods. However, the conditional and cell-
specific ablation of the Gjb2 gene in young mice altered the
development and function of mammary glands [29], indicating
a significant role of the connexin in the post-natal morpho-genesis of an exocrine gland system. Analogous observations
have been made in vitro with thyroid-derived cells. Thus, Cx32
and coupling are lost with passages in culture, together with the
ability of the cells to form follicular structures [125,134], and
these alterations are reverted by exposing cell monolayers to
TSH [134] or by transfecting communication-incompetent
thyrocytes with Cx32, but not Cx43 [135]. While these data
implicate Cx32 in the morphogenesis of thyroid follicles, no
obvious thyroid defect has been reported in mice knock-out for
the Gjb1 gene [28,127].
Several studies also implicate gap junctions in the control
of secretory cell proliferation. Thus, altered growth of the
endocrine pancreas was detected in transgenic mice whose
insulin-producing h-cells were selectively forced to over
express either the ectopic Cx32 [22] or the native Cx36
[136]. Transfection of Cx26 reduced the growth of hepatoma
cells [36], as did that of Cx32 in communication-incompetent
thyroid-derived cells [135], an effect which was not repro-
duced with Cx43 [137]. Pharmacological gap junction
inhibition increased the growth of adrenocortical cells [138],
whereas the exposure of adrenal cells to an antisense cDNA,
which reduced the levels of Cx43, increased their growth rate
[77]. Mice lacking Cx43 have also been shown to have hypo-
developed gonads [21,50], featuring delayed or reduced
growth of the germ cells [61,62]. Thus, in different types of
glands, connexins may contribute to control the size of the
secretory cell population. As yet, however, the relevance of
the latter control for primary cells in vivo has only been
shown in a few cases [21,22,43,50].
8. Conclusions
The work summarized above provides compelling evidence
for a central role of gap junction channels in the function of both
endocrine and exocrine glands. The junctions appear relevant for
both the function of the main parenchymal secretory cells, as
well as for that of the associated vessels and ducts (in exocrine
systems), which cannot be functionally dissociated from
secretory cells when the gland is considered as a whole
functional unit. This review mostly focused on the main
physiological function of glands, which is the synthesis, storage
and release of specific products, and has barely touched on other
functions in which gap junctions may also play a significant role,
such as the developmental growth and acquisition of terminal
differentiation characteristics of secretory cells, their regenera-
tion in the postnatal life, which takes place in fully differentiated
glands such as liver or exocrine pancreas, their interaction with
some of their close by target cells.
Several questions remain to be addressed by a direct
experimental testing, in order to elucidate the reasons why the
connexin-dependent signaling is obligatory for secretory
systems, a stringent requirement that glands share with many,
if not all other multicellular systems. First of all, the
molecular mechanism linking the expression of connexins
and/or the gap junction-dependent coupling of gland cells to
their secretion is not established. Many ions (Ca2+, K+, . . .)
and metabolites (IP3, glycolytic intermediates, nucleotides,
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gers. However, if there is ample evidence that cAMP and
Ca2+ are involved in the control of both gap junction and
secretion [1,5–7,9,19,138], it remains to be demonstrated
whether either one of these two second messengers actually
links in a direct and causal manner the gap junction and the
secretion changes. Future studies should also investigate
whether connexins may control secretion by a mechanism
independent of cell coupling [139] and, if so, whether this
implies some hitherto neglected role of hemichannels, the
interaction of connexins with other proteins and specific
transcriptions factors, or some other mechanism.
Second, the importance of the gap junction-dependent
signaling relative to that ensured by the many other mechan-
isms that interplay to control secretion remains to be
established [1,6]. The finding that chronic alterations of h-
cell connexins are sufficient to reproduce in vivo the defects of
insulin secretion which are observed in type II diabetes
[22,67] indicates a prominent role of the gap junction
signaling, at least in the endocrine pancreas, and raises the
intriguing possibility that connexin defects may contribute to
secretory diseases [1–3,9].
Therefore, a third challenge is to determine whether gap
junction alterations are implicated in the pathogenesis of
secretory disorders. If various alterations of connexin expres-
sion and/or cell-to-cell coupling have been reported in glands
under pathological conditions [1–3,9], no secretory defect has
yet been proven to be associated to either a mutation or a
pathogenic polymorphism of a connexin gene, or to quanti-
tative alterations in the levels of specific connexins, in their
trafficking through the cytoplasm or their clustering and
functioning after insertion into the cell membrane. Eventually,
recent work has outlined the striking similarities, as well as
the significant differences that exist between the connexin,
innexin and pannexin proteins that form gap junctions in
vertebrates, invertebrates and at least some mammals,
including humans, respectively [166–169]. In spite of the
fact that some of the initial work on gap junction function
was carried out in invertebrate glands [26], almost nothing is
known about the functional roles innexins and pannexins may
have on secretory processes, and/or on the development,
differentiation, growth and morphogenesis of exocrine and
endocrine glands. A direct approach of these questions is now
timely to define the hierarchical relationship, if any, that
exists between distinct families of gap junction-forming
proteins, which are co-expressed in a variety of secretory
systems. All these questions open new exciting avenues for
investigations to come.
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